Home
Conditions
Myeloproliferative Disorders

Clinical trial condition

Myeloproliferative Disorders

Explore clinical trials studying Myeloproliferative Disorders. Study availability and eligibility vary by location and protocol.

1,121 public trials 145 recruiting studies

Refine in advanced search Browse all conditions

Myeloproliferative Disorders trial results

Recruiting

A Phase 2 Study to Assess STP938 (Dencatistat) as a Monotherapy in Adults With High Risk Essential Thrombocythaemia - The VECTRA Trial

NCT06786234

Conditions: Blood Coagulation Disorders, Blood Platelet Disorders, Bone Marrow Diseases, +7 more
Locations: Hôpital de la Milétrie, CHU Poitiers, New Aquitaine, France

CHU Brest Brest, France

Institut Paoli-Calmettes Marseille, France

CHU Nantes Nantes, France

View all 14 locations

View Trial Details

Recruiting

Phase I Trial of Vididencel in CML-CP Patients With MRD Under TKI Treatment

NCT07651878

Conditions: Bone Marrow Diseases, CML (Chronic Myelogenous Leukemia), Chronic Disease, +11 more
Locations: Haukeland University Hospital Bergen, Norway

View Trial Details

Recruiting

Impact of Targeted Therapy on Cancer-Related Cognitive Impairment

NCT07638007

Conditions: Bone Marrow Diseases, Chronic Disease, Chronic Lymphocytic Leukemia (CLL), +21 more
Locations: University of Rochester NCORP Research Base Rochester, New York, United States

View Trial Details

Recruiting

Research Platform Myelofibrosis and Anemia

NCT06976918

Conditions: Anemia, Bone Marrow Diseases, Hematologic Diseases, +8 more
Locations: Multiple sites all over Germany Multiple Locations, Germany

View Trial Details

Recruiting

Alpha/Beta T Cell and CD19+ B Cell Depletion in Allogeneic Stem Cell Transplantation in Patients With Malignant Diseases

NCT05800210

Conditions: Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Bone Marrow Diseases, +30 more
Locations: University of Florida Gainesville, Florida, United States

View Trial Details

Recruiting

AlloHCT With PegINFa for Myelofibrosis

NCT05535764

Conditions: Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +3 more
Locations: Huntsman Cancer Institute at the University of Utah Salt Lake City, Utah, United States

View Trial Details

Recruiting

Hyperbaric Oxygen Therapy and Allogeneic Peripheral Blood Stem Cell (PBSC) Transplant

NCT03964506

Conditions: Acute Myeloid Leukemia, Atypical Chronic Myeloid Leukemia, Bone Marrow Diseases, +21 more
Locations: Wilmot Cancer Institute, University of Rochester Rochester, New York, United States

View Trial Details

Recruiting

Donor Stem Cell Transplant With Treosulfan, Fludarabine, and Total-Body Irradiation for the Treatment of Hematological Malignancies

NCT04195633

Conditions: Acute Leukemia, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, +59 more
Locations: Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States

View Trial Details

Recruiting

Open Label Phase 1/2 Study of Tasquinimod in Patients With Primary Myelofibrosis (PMF), Post-Polycythemia Vera Myelofibrosis (Post-PV MF), or Post-Essential Thrombocytosis Myelofibrosis (Post-ET MF)

NCT06327100

Conditions: Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +4 more
Locations: MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Recruiting

Blinatumomab, Methotrexate, Cytarabine, and Ponatinib in Treating Patients With Philadelphia Chromosome-Positive, or BCR-ABL Positive, or Relapsed/Refractory, Acute Lymphoblastic Leukemia

NCT03263572

Conditions: Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Lymphoblastic Leukemia, BCR-ABL1 Fusion Protein Expression, +29 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Myeloproliferative Disorders

Myeloproliferative Disorders trial results

Related conditions